During its March 16, 2021 meeting, the Board approved funding for 10 new comparative clinical effectiveness research (CER) studies and another four projects that aim to accelerate the adoption of useful findings from completed PCORI-funded research in clinical care. Four of the CER studies will focus on second-line medications that would be the most beneficial next step for people with Type 2 diabetes, while another four CER studies will use PCORnet®, the National Patient-Centered Clinical Research Network, to provide new evidence about care of four rare diseases.

The Board also approved the development of three PCORI Funding Announcements (PFAs), which will open in Spring 2021, to seek CER proposals on three critical topics: postpartum complications, particularly among Black, Hispanic/Latina and Native American women; nonsurgical treatments for women experiencing urinary incontinence; and interventions that address mental health conditions in individuals with intellectual and developmental disabilities (IDD). View the news release to learn more about the newly funded studies and projects and the upcoming topic-specific PFAs.

View News Release

In addition, the Board approved a set of four Principles that will guide PCORI in capturing the full range of clinical and patient-centered outcomes data through the research funding application and review process. A new blog post outlines the Principles and the implementation plans.

Read Blog

Meeting Materials

Webinar Recording

Approved Minutes of the March 2021 Board Meeting

All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period. Catch up on past PCORI Board meetings here.


Location Type